Tourmaline Bio’s (TRML) “Buy” Rating Reaffirmed at HC Wainwright
Tourmaline Bio (NASDAQ:TRML – Get Free Report)‘s stock had its “buy” rating reiterated by HC Wainwright in a research note issued to investors on Monday,Benzinga reports. They presently have a $50.00 price objective on the stock. HC Wainwright’s price target would indicate a potential upside of 243.88% from the company’s previous close. HC Wainwright also […]
